Fatemi, S. Hossein, M.D., Ph.D.
Associate Chair for Neuroscience and Translational Research.
Dr. Fatemi’s research and clinical interests have focused on the etiology and treatment of schizophrenia and mood disorders. His primary research interests include molecular causes and studies of the biological basis of schizophrenia and autism. He is an attending at the University Hospital CL Service working with psychiatry residents in their training. Dr. Fatemi has a NARSAD established investigator award, a Stanley Foundation award and a Minnesota Medical foundation grant for the investigation of the expression of several proteins in mouse hippocampus following prenatal exposure to influenza and mapping of the same proteins in the postmortem brains of patients with schizophrenia, bipolar disorder, major depression and autism. Additionally, Dr. Fatemi has a NIH funded pilot project to determine the efficacy of Zyban in Nicotine reduction in schizophrenia patients. His latest publications include articles in Molecular Psychiatry, Neuroreport and Journal of Autism and neurodevelopmental disorders describing his latest findings on involvement of Reelin and Bcl-2 proteins in schizophrenia and autism.Education & Training
Neurodevelopmental origins for schizophrenia and autism, pharmacologic modulation of psychosis and autistic behavior, brain plasticity, neurotoxicity and role of synaptic markers in brain development.
- Residency in Psychiatry - University Hospitals of Cleveland, 1992-96
- Medical Doctor, Case Western Reserve University School of Medicine, 1987-91
- Post-doctoral fellowship, Department of Pharmacology, Texas Health Science Center-Houston
- Post-doctoral fellowship, Department of Anatomy, McGill University, Montreal, Canada
- Post-doctoral fellowship, Natinal Institute of Dental Research, National Institutes of Health, Bethesda, MD
- Doctor of Philosophy in anatomy, University of Nebraska Medical Center-Omaha, 1978-79